Tags

Type your tag names separated by a space and hit enter

[Spice drugs: cannabinoids as a new designer drugs].
Adicciones 2009; 21(3):181-6A

Abstract

Some smokable herbal mixtures under the brand name Spice drugs have been sold on the Internet and in specialised shops (smart shops) since 2004. The mixtures are advertised as an exotic incense blend which releases a rich aroma and not for human consumption. When smoked, Spice drugs products have been reported by products have been reported by some users to have effects similar to those of cannabis. Spice drugs have received intensive attention in drug forums due to the possibility to obtain a non legal substitute of cannabis. Forensic analyses have found different potent synthetic cannabinoid agonists in some Spice drugs products, as JWH-018, CP 47497, JWH-073 and HU-210. There are few data about its pharmacological properties in animals, but nothing about its toxicity. At present, almost nothing is known about the pharmacology, toxicology and safety profile of such compounds in humans, except the opinions of consumers in internet forums. Neither the herbal ingredients of Spice drugs, nor any of the synthetic cannabinoids found in them, are internationally controlled under the 1961 or 1971 UN drug control conventions. Some European countries have recently taken legal actions to ban or otherwise control Spice drugs products and related compounds. These cannabinoid substances can be considered as new products to be added to the list of 'designer drugs'.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Editorial
English Abstract
Research Support, Non-U.S. Gov't

Language

spa

PubMed ID

19718488

Citation

Mustata, Cristina, et al. "[Spice Drugs: Cannabinoids as a New Designer Drugs]." Adicciones, vol. 21, no. 3, 2009, pp. 181-6.
Mustata C, Torrens M, Pardo R, et al. [Spice drugs: cannabinoids as a new designer drugs]. Adicciones. 2009;21(3):181-6.
Mustata, C., Torrens, M., Pardo, R., Pérez, C., & Farré, M. (2009). [Spice drugs: cannabinoids as a new designer drugs]. Adicciones, 21(3), pp. 181-6.
Mustata C, et al. [Spice Drugs: Cannabinoids as a New Designer Drugs]. Adicciones. 2009;21(3):181-6. PubMed PMID: 19718488.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Spice drugs: cannabinoids as a new designer drugs]. AU - Mustata,Cristina, AU - Torrens,Marta, AU - Pardo,Ricardo, AU - Pérez,Clara, AU - ,, AU - Farré,Magi, PY - 2009/9/1/entrez PY - 2009/9/1/pubmed PY - 2009/11/17/medline SP - 181 EP - 6 JF - Adicciones JO - Adicciones VL - 21 IS - 3 N2 - Some smokable herbal mixtures under the brand name Spice drugs have been sold on the Internet and in specialised shops (smart shops) since 2004. The mixtures are advertised as an exotic incense blend which releases a rich aroma and not for human consumption. When smoked, Spice drugs products have been reported by products have been reported by some users to have effects similar to those of cannabis. Spice drugs have received intensive attention in drug forums due to the possibility to obtain a non legal substitute of cannabis. Forensic analyses have found different potent synthetic cannabinoid agonists in some Spice drugs products, as JWH-018, CP 47497, JWH-073 and HU-210. There are few data about its pharmacological properties in animals, but nothing about its toxicity. At present, almost nothing is known about the pharmacology, toxicology and safety profile of such compounds in humans, except the opinions of consumers in internet forums. Neither the herbal ingredients of Spice drugs, nor any of the synthetic cannabinoids found in them, are internationally controlled under the 1961 or 1971 UN drug control conventions. Some European countries have recently taken legal actions to ban or otherwise control Spice drugs products and related compounds. These cannabinoid substances can be considered as new products to be added to the list of 'designer drugs'. SN - 0214-4840 UR - https://www.unboundmedicine.com/medline/citation/19718488/abstract/[Spice_drugs:_cannabinoid L2 - http://www.adicciones.es/index.php/adicciones/article/view/227 DB - PRIME DP - Unbound Medicine ER -